Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Pfizer (NY:PFE)

24.05 +0.15 (+0.63%)
Official Closing Price Updated: 4:10 PM EDT, Sep 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Arvinas Provides Update on Collaboration with Pfizer and Announces Further Actions to Support Value Creation
From Arvinas Inc.
Via GlobeNewswire
Most active S&P500 stocks in Wednesday's session
Looking for the most active S&P500 stocks in today's session? Join us as we dive into the US markets on Wednesday and discover the stocks that are dominating the trading activity and setting the pace... 
Via Chartmill
5 Best High-Yield Dividend Stocks to Buy Now
These five dividend stocks yield between 3.5% and 7.1%, but more importantly, they have the cash flows and business models to keep paying through the next downturn. 
Via The Motley Fool
3 Value Stocks We Find Risky
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few... 
Via StockStory
Nvidia, Pfizer, New Fortress Energy, Tesla, Alphabet: What Sparked Heavy After-Hours Trading In These 5 Stocks?
Via Stocktwits
The Unsettling Normalization: Yield Curve's Un-Inversion Signals Potential Storm Ahead
In a development that has sent ripples of concern through financial markets, the U.S. Treasury yield curve underwent a significant un-inversion in April 2025, following its longest inversion in... 
Via MarketMinute
Topics Bonds Economy
Stay informed about the most active stocks in the S&P500 index on Tuesday's session.
Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Tuesday. Discover the stocks that are generating the highest... 
Via Chartmill
Why Moderna (MRNA) Stock Is Trading Up Today
Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 4% in the morning session after the company announced positive preliminary data for its updated 2025-2026 COVID-19 vaccine, Spikevax®. 
Via StockStory
Topics Death Government
Moderna Reports 8-Fold Jump In Antibodies With Updated Spikevax
Moderna's updated Spikevax shows strong antibody response and safety, targeting dominant COVID-19 variants like LP.8.1 in high-risk and older adults. 
Via Benzinga
3 Undervalued Healthcare Stocks to Buy Now While They're Cheap
In an otherwise hot stock market, healthcare stocks are underperforming. 
Via The Motley Fool
3 Things You Need to Know If You Buy Pfizer Today
Pfizer has an attractive 7.2% dividend yield, but this healthcare giant might be a riskier dividend stock than you want to own. 
Via The Motley Fool
Topics Intellectual Property
3 Magnificent S&P 500 Dividend Stocks Down as Much as 60% to Buy and Hold Forever
A good stock is an even better buy when it's on sale, even if your primary goal is immediate and reliable income. 
Via The Motley Fool
Topics Stocks
3 Mid-Cap Stocks We Keep Off Our Radar
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with... 
Via StockStory
Robert Kennedy Jr. Packs CDC Panel With Vaccine Skeptics Ahead of Key Vote On COVID-19 Shots
Health and Human Services Secretary Robert F. Kennedy Jr. has added five new members to the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices, just days... 
Via Benzinga
Stay informed about the most active stocks in the S&P500 index on Monday's session.
Explore the S&P500 index on Monday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest and driving market movements. 
Via Chartmill
September's Shadow: Will the Notorious 'September Effect' Offer Bargains or Bring Bigger Bears to Wall Street?
As autumn leaves begin to fall, a familiar chill often descends upon the financial markets, not just in temperature but in investor sentiment. September has historically earned a notorious reputation... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
The Weight of Progress: A New Era Dawns for Anti-Obesity Drugs, Reshaping Markets and Health
The global anti-obesity drug market is experiencing an unprecedented surge, driven by groundbreaking advancements in pharmacotherapy, particularly the advent of highly effective GLP-1 receptor... 
Via MarketMinute
Oracle Retreats, Fed Rate Cut Looms, and Vaccine Politics Shake Pharma Stocks
Markets closed Friday in mixed fashion as economic uncertainty and politics clashed with earnings optimism. Oracle's rollercoaster continues, RFK Jr. rattles vaccine makers, and the Fed appears poised... 
Via Chartmill
Topics Artificial Intelligence Economy
1 S&P 500 Stock Worth Investigating and 2 Facing Headwinds
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural... 
Via StockStory
Topics Stocks
Blue Chip Stocks With Fat Dividends: Smart Buy Or Value Trap?
Several top blue-chip stocks sport big dividend yields, but weak cash flow and sector headwinds raise questions of value trap versus smart buy. 
Via Benzinga
1 Reason Every Investor Should Know About Pfizer (PFE) Stock
How does $700 in annual income sound for every $10,000 in shares owned? 
Via The Motley Fool
Why BioNTech Stock Sank by More Than 7% Today
The type of vaccine it's most famous for might be cast in a very unflattering light in the very near future.. 
Via The Motley Fool
Topics Death Government
Why Moderna (MRNA) Shares Are Trading Lower Today
Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 7.8% in the afternoon session after reports revealed Trump administration health officials plan to link COVID-19 vaccines to the deaths of... 
Via StockStory
Topics Death Government
Why Pfizer (PFE) Shares Are Sliding Today
Shares of global pharmaceutical company Pfizer (NYSE:PFE) fell 3.5% in the afternoon session after reports revealed federal health officials are planning to link COVID-19 vaccines to the deaths of... 
Via StockStory
Topics Death Economy Government
Pfizer, Moderna, BioNTech Stocks Tumble After Report Of Plan To Link COVID Vaccines To Child Deaths
Shares of COVID-19 vaccine makers are trading lower Friday. Vaccine stocks fell Friday on a Washington Post report that Trump administration officials plan to link the shots to 25 child deaths. 
Via Benzinga
Topics Government
Uncover the latest developments among S&P500 stocks in today's session.
Curious about the top performers within the S&P500 index one hour before the close of the markets on Friday? Dive into the list of today's session's top gainers and losers for a comprehensive... 
Via Chartmill
The Dawn of a New Era: How GLP-1s, AI, and Robotic Surgery Are Reshaping Healthcare and Investment
The healthcare industry is currently experiencing a transformative "golden age," a period marked by an unprecedented surge in scientific breakthroughs and technological advancements. This era is... 
Via MarketMinute
Topics Artificial Intelligence Bankruptcy Economy
Looking for the most active stocks in the S&P500 index on Friday?
Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention. 
Via Chartmill
3 Stocks Under $50 We Think Twice About
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and... 
Via StockStory
Topics Economy
Merck Advances Childhood Pneumococcal Care With Promising Vaccine Data
Merck's Capvaxive vaccine showed strong immune responses and a comparable safety profile to PPSV23 in high-risk children during the Phase 3 STRIDE-13 trial. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.